Clinical Trial Update: Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether N-acetylcysteine can prevent cisplatin-induced toxicities in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancers
• Cisplatin-induced Toxicity

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Cisplatin Adverse Reaction, Cisplatin Nephrotoxicity | Phase 2 | Status: UNKNOWN